James Investment Research Inc Jazz Pharmaceuticals PLC Transaction History

James Investment Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$125.18 - $143.24 $202,791 - $232,048	-1,620 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$125.55 - $144.48 $426,242 - $490,509	-3,395 Reduced 67.7%	1,620 $231,000
Q1 2019 Apr 26, 2019	BUY	$121.81 - $142.95 $610,877 - $716,894	5,015 New	5,015 $717,000
Q4 2018 Jan 22, 2019	SELL	$115.94 - $166.74 $1.49 Million - $2.14 Million	-12,820 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$161.01 - $180.57 $2.06 Million - $2.31 Million	12,820 New	12,820 $2.16 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.81B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.